The Valley Desk

LetterAdvances in therapyPublished

Response to Letter to the Editor Regarding: 'Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Letter
Venue
Advances in therapy
Published
PubMed ID
41313547
PubMed Central ID
PMC12858576
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal